BFM
ETON icon

Boothbay Fund Management’s Eton Pharmaceutcials ETON Stock Holding History

Boothbay Fund Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Buy
57,516
+1,911
+3% +$56K 0.03% 705
2026
Q1 		$1.37M Buy
+55,605
New +$972K 0.02% 795
2019
Q1 		– Sell
-11,966
Closed -$73K – 792
2018
Q4 		$73K Buy
+11,966
New +$73.4K 0.01% 575

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Boothbay Fund Management's ETON Position: Q2 2026 in Review

Boothbay Fund Management increased its Eton Pharmaceutcials (ETON) stake by 3.4% in Q2 2026, buying an estimated $56K and bringing the position to 57,516 shares worth $2.08M. The position accounts for 0.03% of the portfolio, ranked #705.

Boothbay Fund Management first reported a position in ETON in Q4 2018 and has held it in 3 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Boothbay Fund Management held 57,516 shares of Eton Pharmaceutcials worth $2.08M as of Q2 2026.
  • Boothbay Fund Management bought 1,911 Eton Pharmaceutcials shares in Q2 2026, an estimated $56K.
  • Eton Pharmaceutcials made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #705 holding.
  • Boothbay Fund Management first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 3 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.